Its blockade has been shown to inhibit autophagy in cancer, and when used in combination with PD-1 inhibition in a mouse model of HCC, decreased tumor burden by inducing the penetration of lymphocytes [137]. Here, PDCD1 is linked to hepatocellular carcinoma.